Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,528
Closed -$212K 259
2024
Q1
$212K Buy
+1,528
New +$192K 0.02% 261
2023
Q3
Sell
-1,859
Closed -$239K 315
2023
Q2
$239K Sell
1,859
-44
-2% -$5.32K 0.02% 350
2023
Q1
$221K Sell
1,903
-103
-5% -$11.5K 0.02% 389
2022
Q4
$227K Buy
+2,006
New +$220K 0.02% 375
2022
Q2
Sell
-1,960
Closed -$251K 466
2022
Q1
$251K Sell
1,960
-344
-15% -$37.6K 0.02% 398
2021
Q4
$309K Buy
+2,304
New +$331K 0.02% 232

Other funds holding DXCM

American Trust's DXCM Position: Q2 2024 in Review

American Trust sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,528 shares — an estimated $212K sold.

American Trust first reported a position in DXCM in Q4 2021 and held it in 6 quarters. The position peaked at $309K in Q4 2021. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • American Trust reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • American Trust sold 1,528 DexCom shares in Q2 2024, an estimated $212K.
  • American Trust first reported a position in DexCom in Q4 2021 and held it in 6 quarters.
  • American Trust's DexCom position peaked at $309K in Q4 2021.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on American Trust's 13F filing for Q2 2024, filed 12 Sep 2024.